Skip to content

Faculty profile

Nick Daneman

Back to faculty
ResearcherQueen's University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

    CANADIAN MEDICAL ASSOCIATION JOURNAL · 2022

  • Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19

    Journal of the American Medical Association (JAMA) · 2020

  • Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients

    Critical Care Medicine · 2017

All 4 publications

Latest funding

  • RATIONAL (Role of Antibiotic Therapy or Immunoglobulin On iNfection in hAematoLogy) Platform Trial: An RCT of continuing immunoglobulin therapy, or stopping with or without prophylactic antibiotics, on infection rate in patients with acquired hypogammaglobulinemia secondary to haematological malignancies

    CIHR · 2024 · Co-investigator

    $1,197,227
  • Vancomycin dosing for serious MRSA infections: A non-inferiority randomized trial of trough level versus AUC/MIC.

    CIHR · 2024 · Principal investigator

    $749,700
All 2 grants and awards
Something wrong or missing on this profile? Suggest a correction